US EditionPublished • loading... • Updated
Bioprocessing Advances Push iPSC-Derived Neurons Toward the Clinic
Efforts to efficiently manufacture human neurons from induced pluripotent stem cells (iPSCs) are rapidly transforming the landscape of neuroscience research, drug discovery, and emerging cell-based therapies. In a new review, Satoru Morimoto, MD, PhD, of Keio University’s Regenerative Medicine Research Center in Japan, and his colleagues highlight the fast-accelerating progress—and the remaining engineering hurdles—in scaling iPSC bioprocessing …
1 Articles
1 Articles
Bioprocessing Advances Push iPSC-Derived Neurons Toward the Clinic
Efforts to efficiently manufacture human neurons from induced pluripotent stem cells (iPSCs) are rapidly transforming the landscape of neuroscience research, drug discovery, and emerging cell-based therapies. In a new review, Satoru Morimoto, MD, PhD, of Keio University’s Regenerative Medicine Research Center in Japan, and his colleagues highlight the fast-accelerating progress—and the remaining engineering hurdles—in scaling iPSC bioprocessing …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
